About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Igh
immunoglobulin heavy chain complex
MGI:96442
118 phenotypes from multigenic genotypes
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Aicdatm1(cre)Mnz/Aicda+
Ightm3Mnz/Igh+
Myctm39Mnz/Myc+
involves: 129P2/OlaHsd * C57BL/6 		abnormal B cell physiology J:145691
spontaneous chromosome breakage J:145691
Aicdatm1(cre)Mnz/Aicda+
Ightm3Mnz/Igh+
Myctm37Mnz/Myc+
involves: 129P2/OlaHsd * C57BL/6 		abnormal B cell physiology J:145691
spontaneous chromosome breakage J:145691
Aicdatm1Hon/Aicdatm1Hon
Blmtm3Brd/Blmtm3Brd
Ightm4.1Mnz/Igh+
Trp53bp1tm1Jc/Trp53bp1tm1Jc
involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj 		normal immune system phenotype J:194603
Aicdatm1Hon/Aicdatm1Hon
Exo1tm1Wed/Exo1tm1Wed
Ightm4.1Mnz/Igh+
involves: C57BL/6 * CBA/JNCrlj * SJL 		abnormal immunoglobulin heavy chain V(D)J recombination J:194603
Aicdatm1Hon/Aicdatm1Hon
Exo1tm1Wed/Exo1tm1Wed
Ightm4.1Mnz/Igh+
Trp53bp1tm1Jc/Trp53bp1tm1Jc
involves: 129 * C57BL/6 * CBA/JNCrlj * SJL 		abnormal immunoglobulin heavy chain V(D)J recombination J:194603
Aicdatm1Hon/Aicdatm1Hon
Ightm3Mnz/Igh+
Myctm37Mnz/Myc+
involves: C57BL/6 * CBA 		induced chromosome breakage J:145691
Aicdatm1Hon/Aicdatm1Hon
Ightm3Mnz/Ightm4.1Mnz
Trp53bp1tm1Jc/Trp53bp1tm1Jc
involves: 129 * C57BL/6 * CBA 		abnormal class switch recombination J:159173
Aicdatm1Hon/Aicdatm1Hon
Ightm4.1Mnz/Igh+
involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj 		abnormal immunoglobulin heavy chain V(D)J recombination J:194603
Aicdatm1Hon/Aicdatm1Hon
Ightm4.1Mnz/Igh+
Trp53bp1tm1Jc/Trp53bp1tm1Jc
involves: 129 * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj 		abnormal immunoglobulin heavy chain V(D)J recombination J:194603
Blnktm1Kplm/Blnktm1Kplm
Ightm4Cgn/Igh+
Igktm1Rsky/Igk+
involves: 129P2/OlaHsd 		abnormal B cell differentiation J:120460
decreased B cell number J:120460
increased pre-B cell number J:120460
increased transitional stage B cell number J:120460
Cd19tm1(cre)Cgn/Cd19tm1(cre)Cgn
Ightm1Mnz/Ightm1Mnz
involves: 129P2/OlaHsd * C57BL/6 		abnormal B cell physiology J:75653
Cd19tm1(cre)Cgn/Cd19tm1(cre)Cgn
Ightm2Mnz/Ightm2Mnz
involves: 129P2/OlaHsd * C57BL/6 		abnormal B cell physiology J:75653
Cd22tm1Lam/Cd22tm1Lam
Ightm1.2Rsky/Igh+
involves: 129 * BALB/c * C57BL/6 		abnormal class switch recombination J:125719
Cd22tm1Lam/Cd22tm1Lam
Ightm1.2Rsky/Ightm1.2Rsky
involves: 129 * BALB/c * C57BL/6 		abnormal B cell activation J:125719
decreased B-1a cell number J:125719
Cd79atm4.1Cgn/Cd79atm4.1Cgn
Ightm1.2Rsky/Igh+
involves: BALB/c * C57BL/6 		abnormal pro-B cell differentiation J:125719
Cd79atm5.1Cgn/Cd79a+
Ightm1.2Rsky/Igh+
involves: 129 * BALB/c * C57BL/6 		abnormal class switch recombination J:125719
Cd79atm5.1Cgn/Cd79atm5.1Cgn
Ightm1.2Rsky/Igh+
involves: 129 * BALB/c * C57BL/6 		abnormal class switch recombination J:125719
Cd79atm5.1Cgn/Cd79atm5.1Cgn
Ightm1.2Rsky/Ightm1.2Rsky
involves: 129 * BALB/c * C57BL/6 		abnormal B cell morphology J:125719
abnormal class switch recombination J:125719
decreased immature B cell number J:125719
decreased mature B cell number J:125719
decreased pre-B cell number J:125719
decreased T cell number J:125719
increased B-1b cell number J:125719
increased pro-B cell number J:125719
Commd8tm1.1Ksuz/Commd8tm1.1Ksuz
Ightm1Mnz/Igh+
Cd79atm1(cre)Reth/Cd79a+
involves: 129P2/OlaHsd * BALB/c * C57BL/6NSlc * SJL 		abnormal spleen B cell follicle morphology J:278399
Emv30b/Emv30b
Prkdcscid/Prkdcscid
Tg(IghH280)48Dvs/?
Tg(IgkH280)934Dvs/?
NOD.Cg-Emv30b Prkdcscid Tg(IghH280)48Dvs Tg(IgkH280)934Dvs/Dvs 		normal homeostasis/metabolism phenotype J:274578
Ezh2tm1Tara/Ezh2tm1Tara
Ightm2Cgn/?
Tg(Mx1-cre)1Cgn/0
involves: 129P2/OlaHsd * C57BL/6 * CBA 		normal immune system phenotype J:83216
Fnip1Gt(RRM154)Byg/Fnip1Gt(RRM154)Byg
Ightm2Cgn/Ightm2Cgn
involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL 		absent B cells J:189078
absent B-2 B cells J:189078
decreased B-1 B cell number J:189078
Fnip1tm1.2Baba/Fnip1tm1.2Baba
Ightm2Cgn/Ightm2Cgn
involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL 		absent B cells J:189078
absent B-2 B cells J:189078
decreased B-1 B cell number J:189078
Foxo1tm1.1Rdp/Foxo1+
Igh-Jtm1Cgn/Ightm4Cgn
Tg(Cr2-cre)3Cgn/0
involves: 129P2/OlaHsd * 129S1/Sv 		increased B cell number J:157297
Foxo1tm1Rdp/Foxo1tm1.1Rdp
Igh-Jtm1Cgn/Ightm4Cgn
Tg(Cr2-cre)3Cgn/0
involves: 129P2/OlaHsd * 129S1/Sv 		absent marginal zone B cells J:157297
increased B cell number J:157297
Ggta1tm1Jbl/Ggta1+
Ightm1Jiac/Igh+
Igktm1Jiac/Igktm1Jiac
involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 		decreased mature B cell number J:133032
Ggta1tm1Jbl/Ggta1+
Ightm1Jiac/Ightm1Jiac
Igktm1Jiac/Igk+
involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 		decreased mature B cell number J:133032
Ggta1tm1Jbl/Ggta1+
Ightm1Jiac/Ightm1Jiac
Igktm1Jiac/Igktm1Jiac
involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 		abnormal B cell physiology J:133032
abnormal B cell selection J:133032
decreased mature B cell number J:133032
Gpr183tm1.2Rbr/Gpr183tm1.2Rbr
Ightm1Rbr/Ightm1Rbr
Tg(IgkHyHEL10)1Rbr/0
involves: C57BL/6 * FVB/N * SJL 		abnormal B cell physiology J:151883
abnormal B cell proliferation J:151883
decreased B cell number J:151883
decreased IgG1 level J:151883
decreased IgM level J:151883
decreased plasma cell number J:151883
impaired B cell migration J:151883
Gt(ROSA)26Sortm4(Ikbkb)Rsky/Gt(ROSA)26Sortm4(Ikbkb)Rsky
Igh-Jtm1Cgn/Ightm4Cgn
Tg(Cr2-cre)3Cgn/0
involves: 129P2/OlaHsd * C57BL/6 		increased B cell number J:157297
Gt(ROSA)26Sortm8(Map2k1*,EGFP)Rsky/Gt(ROSA)26Sortm8(Map2k1*,EGFP)Rsky
Igh-Jtm1Cgn/Ightm4Cgn
Tg(Cr2-cre)3Cgn/0
involves: 129P2/OlaHsd * C57BL/6 		decreased mature B cell number J:157297
Gt(ROSA)26Sortm9(Rac1*,EGFP)Rsky/Gt(ROSA)26Sortm9(Rac1*,EGFP)Rsky
Igh-Jtm1Cgn/Ightm4Cgn
Tg(Cr2-cre)3Cgn/0
involves: 129P2/OlaHsd * C57BL/6 		decreased mature B cell number J:157297
H2axtm1Nus/H2axtm1Nus
Ightm1Mnz/Ightm1Mnz
involves: 129P2/OlaHsd 		normal immune system phenotype J:120658
H2axtm1Nus/H2axtm1Nus
Ightm2Mnz/Ightm2Mnz
involves: 129P2/OlaHsd 		normal immune system phenotype J:120658
Igh-Jtm1Cgn/Ightm1Leck
involves: 129P2/OlaHsd * C57BL/6 		abnormal immunoglobulin light chain V-J recombination J:144033
Igh-Jtm1Cgn/Ightm4Cgn
Tg(Cr2-cre)3Cgn/0
involves: 129P2/OlaHsd 		decreased mature B cell number J:157297
Igh-Jtm1Cgn/Ightm4Cgn
Tg(Cr2-cre)3Cgn/0
Not Specified 		decreased B cell number J:79299
decreased follicular B cell number J:79299
decreased marginal zone B cell number J:79299
Igh-Jtm1Cgn/Ightm11.1Cgn
involves: 129P2/OlaHsd 		abnormal B cell differentiation J:113434
Igh-Jtm1Dhu/Ightm1Tim
involves: 129X1/SvJ * C57BL/6 		abnormal B cell differentiation J:88410
abnormal B cell morphology J:87624
abnormal immune system organ morphology J:87624
abnormal spleen marginal zone morphology J:87624
abnormal spleen morphology J:87624
Igh-Jtm1Dhu/Ightm2Tim
involves: 129X1/SvJ * C57BL/6 		abnormal lymph node morphology J:87624
abnormal spleen morphology J:87624
decreased marginal zone B cell number J:87624
Igh-Jtm1Dhu/Ightm3Tim
involves: 129 * C57BL/6 		abnormal B cell differentiation J:102308
decreased B cell number J:102308
IghdeltaD/Ightm11.1Cgn
involves: C57BL/6 * DBA/2 		abnormal B cell differentiation J:113434
Ightm1(IGH)Vlcg/Ightm1(IGH)Vlcg
involves: 129S6/SvEvTac * C57BL/6N 		reduced male fertility J:208619
Ightm1(IGH)Vlcg/Ightm1(IGH)Vlcg
Igktm1(IGK)Vlcg/Igktm1(IGK)Vlcg
involves: 129S6/SvEvTac * C57BL/6N 		normal immune system phenotype J:208620
reduced male fertility J:208619
Ightm1(Ighppc1-5)Cche/Igh+
B6.Cg-Ightm1(Ighppc1-5)Cche 		normal immune system phenotype J:138356
increased autoantibody level J:138356
Ightm1(Myc)Janz/Igh+
involves: 129X1/SvJ * C57BL/6 		abnormal tumor morphology J:160845
enlarged lymph nodes J:96785
enlarged spleen J:96785
increased B cell apoptosis J:96785
increased B cell derived lymphoma incidence J:96785, J:160845
increased B cell proliferation J:96785
increased plasmacytoma incidence J:96785, J:160845
increased tumor incidence J:96785, J:160845
lymphoid hyperplasia J:96785
Ightm1(Myc)Janz/Igh+
Mdm4tm1.1Wahl/Mdm4tm1.1Wahl
involves: 129S/Sv * C57BL/6 		enlarged liver J:150341
enlarged lymph nodes J:150341
enlarged spleen J:150341
increased B cell derived lymphoma incidence J:150341
increased lymphoma incidence J:150341
increased splenocyte proliferation J:150341
premature death J:150341
Ightm1(Myc)Janz/Igh+
Tg(Emu-FGFR3)A5Wmk/0
involves: 129X1/SvJ * C57BL/6 * FVB/N 		abnormal tumor morphology J:160845
increased B cell derived lymphoma incidence J:160845
increased plasmacytoma incidence J:160845
increased tumor incidence J:160845
Ightm1(Myc)Janz/Igh+
Tg(Emu-FGFR3)D3Wmk/0
involves: 129X1/SvJ * C57BL/6 * FVB/N 		abnormal tumor morphology J:160845
increased B cell derived lymphoma incidence J:160845
increased plasmacytoma incidence J:160845
increased tumor incidence J:160845
Ightm1(PAX5)Mbu/Igh+
B6.Cg-Ightm1(PAX5)Mbu 		abnormal heart morphology J:118111
abnormal kidney morphology J:118111
abnormal liver morphology J:118111
abnormal lung morphology J:118111
abnormal lymph node morphology J:118111
abnormal salivary gland morphology J:118111
abnormal spleen morphology J:118111
abnormal T cell differentiation J:118111
abnormal thymus morphology J:118111
decreased double-negative T cell number J:118111
decreased double-positive T cell number J:118111
enlarged lymph nodes J:118111
enlarged spleen J:118111
enlarged thymus J:118111
increased lymphoma incidence J:118111
increased pro-B cell number J:118111
increased T cell derived lymphoma incidence J:118111
premature death J:118111
thymus hypoplasia J:118111
Ightm1(PAX5)Mbu/Igh+
Pax5tm1Mbu/Pax5tm1Mbu
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * CBA 		abnormal B cell differentiation J:118111
decreased B cell number J:118111
normal immune system phenotype J:118111
Ightm1(PAX5)Mbu/Ightm1(PAX5)Mbu
B6.Cg-Ightm1(PAX5)Mbu 		abnormal heart morphology J:118111
abnormal kidney morphology J:118111
abnormal liver morphology J:118111
abnormal lung morphology J:118111
abnormal lymph node morphology J:118111
abnormal salivary gland morphology J:118111
abnormal spleen morphology J:118111
abnormal T cell differentiation J:118111
abnormal thymus morphology J:118111
decreased double-negative T cell number J:118111
decreased double-positive T cell number J:118111
enlarged lymph nodes J:118111
enlarged spleen J:118111
enlarged thymus J:118111
increased lymphoma incidence J:118111
increased pro-B cell number J:118111
increased T cell derived lymphoma incidence J:118111
premature death J:118111
thymus hypoplasia J:118111
Ightm1(VH558)Mss/Igh+
involves: FVB/N 		abnormal B cell differentiation J:130421
Ightm1(VH558)Mss/Ightm1(VH558)Mss
involves: FVB/N 		abnormal B cell differentiation J:130421
Ightm1.1(b12)Nemz/Ightm1.1(b12)Nemz
involves: C57BL/6N * FVB/N 		decreased IgM level J:205766
decreased immature B cell number J:205766
increased B cell number J:205766
Ightm1.1(b12)Nemz/Ightm1.1(b12)Nemz
Igktm1.1(b12)Nemz/Igktm1.1(b12)Nemz
involves: C57BL/6N * C57BL/6NTac * FVB/N 		decreased IgM level J:205766
decreased immature B cell number J:205766
normal immune system phenotype J:205766
increased B cell number J:205766
Ightm1.1(Igh564)Tik/Ightm1.1(Igh564)Tik
Igktm1(Igk564)Tik/Igktm1(Igk564)Tik
B6.129S4-Igktm1(Igk564)Tik Ightm1(Igh564)Tik 		abnormal glomerular mesangium morphology J:113555
abnormal podocyte morphology J:113555
expanded mesangial matrix J:113555
glomerulonephritis J:113555
increased mesangial cell number J:113555
podocyte foot process effacement J:113555
Ightm1.1(Rr361-HBB)Aak/Ightm1.1(Rr361-HBB)Aak
129.129S2(Cg)-Ightm1.1(Rr361-HBB)Aak 		abnormal class switch recombination J:333279
decreased IgA level J:333279
decreased IgE level J:333279
decreased IgG1 level J:333279
decreased IgG2a level J:333279
decreased IgG2b level J:333279
Ightm1.1(Tag)Rwhe/Igh+
involves: 129P2/OlaHsd * C57BL/6 		abnormal B cell morphology J:150315
enlarged spleen J:150315
increased B cell number J:150315
increased chronic lymphocytic leukemia incidence J:150315
increased leukemia incidence J:150315
lymph node hyperplasia J:150315
Ightm1.1(Tag)Rwhe/Igh+
Trp53tm1Tyj/Trp53tm1Tyj
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 		increased chronic lymphocytic leukemia incidence J:150315
increased leukemia incidence J:150315
Ightm1.1Twin/Ightm1.1Twin
Plcg2Ali5/Plcg2+
involves: 129 * 129S4/SvJae * C3HeB/FeJ * C57BL/6 		normal immune system phenotype J:174233
increased B-1a cell number J:174233
Ightm1.1Twin/Ightm1.1Twin
Siglecgtm1Lnit/Siglecgtm1Lnit
involves: 129 * 129S4/SvJae * BALB/c * C57BL/6 		normal immune system phenotype J:174233
Ightm1.2Rsky/Igh+
Tnfrsf13ctm1Mass/Tnfrsf13ctm1Mass
involves: BALB/c * C57BL/6 		decreased mature B cell number J:125719
Ightm1Cys/Igh+
Tg(Igk)5Cys/0
B6.Cg-Ightm1Cys Tg(Igk)5Cys 		abnormal B cell physiology J:118931
normal immune system phenotype J:118931
Ightm1Cys/Igh+
Tg(Igk)5Cys/0
Tg(UBC-GFP)30Scha/Tg(UBC-GFP)30Scha
involves: 129X1/SvJ * C57BL/6 * CBA 		normal immune system phenotype J:118931
Ightm1Kplm/Igh+
Tg(Igk-V4CH27)1-2Shc/0
involves: C57BL/6 * SJL 		increased B cell number J:115292
Ightm1Kplm/Ightm4Cgn
Tg(Igk-V4CH27)1-2Shc/0
involves: 129P2/OlaHsd * C57BL/6 * SJL 		increased B cell number J:115292
Ightm1Ktom/Ightm1Ktom
Igktm1Ktom/Igktm1Ktom
Tc(HSA14)SC20Ktom/0
Tc(HSA2)W23Ktom/0
involves: C57BL/6NCrlj * CBA/JNCrlj * ICR 		abnormal B cell physiology J:59894
Ightm1Ktom/Ightm1Ktom
Tc(HSA2)W23Ktom/0
involves: C57BL/6NCrlj * CBA/JNCrlj * ICR 		abnormal B cell physiology J:59894
Ightm1Leck/Igh+
involves: 129P2/OlaHsd * C57BL/6 		abnormal B cell morphology J:144033
abnormal B-1a B cell morphology J:144033
abnormal immature B cell morphology J:144033
abnormal immunoglobulin light chain V-J recombination J:144033
abnormal mature B cell morphology J:144033
Ightm1Leck/Ightm1Leck
involves: 129P2/OlaHsd * C57BL/6 		decreased B cell number J:144033
Ightm1Mnz/Ightm1Mnz
Dis3tm1.1Uba/Dis3tm1.1Uba
Aicdatm1(cre)Uba/Aicda+
involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 		abnormal somatic hypermutation frequency J:302856
Ightm1Mnz/Ightm1Mnz
Lyntm1Sor/Lyntm1Sor
involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 		abnormal B cell physiology J:75653
increased B cell proliferation J:75653
Ightm1Rbr/Igh+
Tg(IgkHyHEL10)1Rbr/0
involves: C57BL/6 		abnormal B cell morphology J:132538
abnormal B-2 B cell morphology J:132538
increased IgA level J:132538
increased IgG1 level J:132538
increased IgG2a level J:132538
increased IgG2b level J:132538
increased IgG3 level J:132538
increased IgM level J:132538
increased immature B cell number J:132538
increased immunoglobulin level J:132538
Ightm1Rbr/Igh+
Tg(IgkHyHEL10)1Rbr/0
Tg(ML5sHEL)5Ccg/0
involves: C57BL/6 * C57BL/6JSfd 		abnormal B cell anergy J:132538
abnormal B cell morphology J:132538
decreased follicular B cell number J:132538
decreased marginal zone B cell number J:132538
increased immature B cell number J:132538
Ightm2(IGH)Vlcg/Ightm2(IGH)Vlcg
involves: 129S6/SvEvTac * C57BL/6N 		reduced male fertility J:208619
Ightm2(IGH)Vlcg/Ightm2(IGH)Vlcg
Igktm2(IGK)Vlcg/Igktm2(IGK)Vlcg
involves: 129S6/SvEvTac * C57BL/6N 		normal immune system phenotype J:208620
reduced male fertility J:208619
Ightm2.1(4E10)Nemz/Ightm2.1(4E10)Nemz
Igktm2.1(4E10)Nemz/Igktm2.1(4E10)Nemz
involves: C57BL/6 * C57BL/6N * C57BL/6NTac * FVB/N 		decreased B cell number J:101977
decreased IgG level J:101977
decreased IgM level J:101977
Ightm2.1(Tag)Rwhe/Igh+
involves: 129P2/OlaHsd * C57BL/6 		abnormal B cell morphology J:150315
enlarged spleen J:150315
increased B cell number J:150315
increased chronic lymphocytic leukemia incidence J:150315
increased leukemia incidence J:150315
lymph node hyperplasia J:150315
Ightm2.1(Tag)Rwhe/Igh+
Trp53tm1Tyj/Trp53tm1Tyj
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 		increased chronic lymphocytic leukemia incidence J:150315
increased leukemia incidence J:150315
Ightm2Cgn/Igh+
Rr158tm1Cgn/Rr158tm1Cgn
Arhgef1tm1.1Rmt/Arhgef1tm1.1Rmt
involves: 129P2/OlaHsd * C57BL/6 		abnormal B cell migration J:113295
Ightm2Cgn/Igh+
Xrcc6tm1Fwa/Xrcc6tm1Fwa
involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 		abnormal B cell differentiation J:44361
Ightm2Cgn/Igh+
Igktm1Rsky/Igk+
either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c) 		abnormal B cell differentiation J:111431
absent pre-B cells J:111431
Ightm2Cgn/Igh+
Igktm2Rsky/Igk+
involves: 129P2/OlaHsd 		abnormal class switch recombination J:150435
Ightm2Cgn/Igh+
Igktm2Rsky/Igk+
Prkdcscid/Prkdcscid
involves: 129P2/OlaHsd * BALB/c * C57BL/Ka 		abnormal class switch recombination J:150435
Ightm2Cgn/Ightm2Cgn
Igktm1Rsky/Igktm1Rsky
Lig4tm1Fwa/Lig4tm1Fwa
Trp53tm1Tyj/Trp53tm1Tyj
involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac 		abnormal class switch recombination J:126758
Ightm2Cgn/Ightm2Cgn
Igktm1Rsky/Igktm1Rsky
Trp53tm1Tyj/Trp53tm1Tyj
Xrcc4tm1Fwa/Xrcc4tm1Fwa
involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac 		abnormal class switch recombination J:126758
increased cellular sensitivity to ionizing radiation J:126758
spontaneous chromosome breakage J:126758
Ightm2Mnz/Ightm2Mnz
Lyntm1Sor/Lyntm1Sor
involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 		abnormal B cell physiology J:75653
increased B cell proliferation J:75653
Ightm2Rsky/Igh+
Igktm1Rsky/Igk+
either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c) 		abnormal B cell differentiation J:111431
Ightm2Rsky/Igh+
Igktm2Rsky/Igk+
either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c) 		abnormal B cell differentiation J:111431
Ightm3(IGH)Vlcg/Ightm3(IGH)Vlcg
involves: 129S6/SvEvTac * C57BL/6NTac 		decreased litter size J:277644
impaired fertilization J:277644
impaired sperm migration in female genital tract J:277644
reduced male fertility J:277644
normal reproductive system phenotype J:277644
Ightm3.1(IGH)Vlcg/Ightm3.1(IGH)Vlcg
involves: 129S6/SvEvTac * C57BL/6N 		reduced male fertility J:208619
Ightm3.1(IGH)Vlcg/Ightm3.1(IGH)Vlcg
Igktm3.1(IGK)Vlcg/Igktm3.1(IGK)Vlcg
involves: 129S6/SvEvTac * C57BL/6N 		normal immune system phenotype J:208620
reduced male fertility J:208619
Ightm3.1Tim/Igh+
involves: 129 * C57BL/6 		abnormal B cell differentiation J:102308
abnormal bone marrow cell number J:102308
abnormal spleen B cell follicle morphology J:102308
Ightm3Tim/Igh+
involves: 129 * C57BL/6 		abnormal B cell differentiation J:102308
abnormal bone marrow cell number J:102308
abnormal spleen B cell follicle morphology J:102308
Ightm4.1(IGH,Adam6a,Adam6b)Vlcg/Ightm4.1(IGH,Adam6a,Adam6b)Vlcg
involves: 129S6/SvEvTac * C57BL/6NTac * SJL 		normal reproductive system phenotype J:277644
Ightm4Cog/Igh+
involves: 129S2/SvPas * C57BL/6 		decreased IgM level J:109988
increased IgA level J:109988
Ightm4Cog/Ightm4Cog
involves: 129S2/SvPas * C57BL/6 		absent Peyer's patches J:109988
absent spleen germinal center J:109988
small spleen J:109988
Ighmtm1Cgn/Ightm3Tim
involves: 129 * C57BL/6 		abnormal B cell differentiation J:102308
decreased B cell number J:102308
Ighmtm1Msn/Ighmtm1Msn
Tg(Igh-6)1Msn/?
B6.129S-Ighmtm1Msn 		abnormal B-1a B cell morphology J:80656
abnormal splenic cell ratio J:80656
decreased follicular B cell number J:80656
decreased IgM level J:80656
increased marginal zone B cell number J:80656
Inpp5dtm1Rav/Inpp5dtm1Rav
Cd79atm1(cre)Reth/Cd79a+
Tg(IghAb36-65)1Wys/0
involves: 129 * BALB/c * C57BL/6 * FVB/N 		abnormal B cell anergy J:178833
abnormal B cell negative selection J:178833
decreased B cell number J:178833
increased autoantibody level J:178833
increased plasma cell number J:178833
Tg(IghH280)48Dvs/?
Tg(IgkH280)934Dvs/?
NOD/ShiLtDvs-Tg(IghH280)48Dvs Tg(IgkH280)934Dvs/Dvs 		increased susceptibility to autoimmune diabetes J:274578
Tg(SV40-Igh-64C8)H3Hon/0
Tg(SV40-Igk4C8)L1Hon/0
involves: C57BL/6 		abnormal B cell clonal deletion J:139864
abnormal B cell number J:139864
decreased hematocrit J:139864
hemolytic anemia J:139864
increased anti-erythrocyte antigen antibody level J:139864
increased erythrocyte clearance J:139864
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
06/12/2024
MGI 6.13 		The Jackson Laboratory